The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

When states legalize medical and recreational cannabis, fewer prescriptions for anxiety are filled, but more for depression ...

Mississippi consistently ranks in the top five in the nation for its rates of antipsychotic drugging in nursing homes.

But the healthcare system in the US still struggles to provide adequate care for those with serious mental illness ...